Taking Mounjaro for the First Time: What to Decide Before You Inject

Mounjaro is a once-weekly subcutaneous injection using a pre-filled KwikPen; each pen contains four weekly doses at the same strength.
The 2.5 mg starting dose is designed to let your system adjust, not to produce rapid weight loss — most people move up in dose only after a prescriber review.
Three licensed injection sites are available: the abdomen, outer thigh, and upper arm; rotating between them reduces localised skin reactions.
Common side effects (mainly nausea, indigestion and loose stools) are most noticeable in the first few days after each dose and typically ease within one to two weeks.

Taking Mounjaro for the first time raises one core question: am I doing this right? The short answer is that the 2.5 mg KwikPen is designed to be used by patients at home, and the injection itself takes under a minute once you know the sequence. That said, three decisions made before the pen even leaves the fridge have a bigger effect on your experience than the injection technique itself. Mounjaro (tirzepatide) is a prescription-only medicine, and everything below reflects the guidance your prescriber will have given you alongside your prescription. If anything conflicts with your Patient Information Leaflet, the leaflet wins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The three decisions that shape your first Mounjaro injection

Deciding when to take your first dose — and locking in the same day each week

Picking a day of the week sounds trivial. It is not. Mounjaro stays active for roughly seven days, so drifting your injection day forward or backward by even a couple of days compresses or stretches the interval in a way that can amplify side effects. Choose a day that fits your routine reliably (many people pick a weekend morning because they can take it easy if nausea arrives) and then stay on it. A useful guide on choosing the best time of day for your Mounjaro injection covers how time of day interacts with mealtimes, which matters more as your dose increases.

Once you have a day, note it somewhere you will actually see: a phone calendar event set to repeat weekly works well. Missing the scheduled day by more than four days is a clinical question for your prescriber, not something to improvise on. The guidance on injection timing goes into the specific scenarios, dose missed, day moved, that kind of thing.

One quick habit worth building from week one: before you open the pen tray, check the expiry date printed on the box. It takes five seconds and removes any doubt. Straightforward, but easy to skip when you are focused on the injection itself.

Deciding where on your body to inject, and how to rotate

Three sites are licensed for Mounjaro: the abdomen (at least five centimetres from the navel), the front or outer thigh, and the upper arm. All three deliver the medicine into the fatty layer beneath the skin, which is where absorption happens. Each site works. The choice on day one usually comes down to which you can reach confidently and which feels least intimidating.

Rotation matters more than people expect. Injecting repeatedly into the same small patch of skin can cause hardening (lipohypertrophy), which affects how reliably the medicine is absorbed. A simple system: divide each site into zones and move one zone to the right each week, returning to the start after a full circuit. Some people vary by day of the week rather than zone. Either approach works; what matters is not landing on the same two-centimetre patch twice in succession.

The step-by-step guide to your first Mounjaro injection covers site selection alongside pen technique in practical detail, including what a correctly placed injection looks and feels like. If you are uncertain about technique, that is worth reading before week one rather than after. The broader injection overview also sets out what to look for at the injection site in the days that follow.

Deciding how to handle the side effects that may follow

Most people feel something in the first 48 hours after their first Mounjaro dose. Nausea is the most reported, followed by indigestion and changes in bowel habit. This is not a sign that something has gone wrong, it reflects the medicine slowing gastric emptying, which is part of how it works. For most people, symptoms settle within one to two weeks. The NHS tirzepatide medicines page lists the full side-effect profile and is worth bookmarking.

Small, frequent meals tend to reduce nausea more reliably than eating less overall. Staying well-hydrated matters too, particularly because the GI effects can cause fluid loss faster than you notice. Alcohol amplifies nausea in the early weeks, worth knowing before a social occasion falls in week one or two.

One effect people are not always warned about: fatigue. Some people feel genuinely tired for a day or two after the first injection. That is common and usually brief. If you experience severe, persistent stomach pain that radiates toward your back, that is a different matter entirely, seek medical help promptly, as this can be a sign of pancreatitis, which the MHRA has highlighted as an infrequent but serious side effect of GLP-1 medicines. You can also report any suspected side effects through the MHRA Yellow Card scheme.

Thinking about whether Mounjaro is right for you, or reviewing your current treatment? Our free consultation with a GPhC-registered prescriber covers eligibility, your medical history and any questions about starting treatment.

What to do with the pen after your first injection

The KwikPen automatically retracts its needle after use and locks, so there is no capping required. Even so, used pens are sharps and need proper disposal, not the household bin. A sharps container is the correct route; local council disposal schemes and some pharmacies accept sealed containers. Your Patient Information Leaflet includes disposal instructions specific to your pen.

Storage between doses matters too. The pen should go back into the fridge (2–8°C) after use; never freeze it. For the exact room-temperature window permitted outside refrigeration, the guide to storing Mounjaro after first use covers the specifics the SmPC sets out, which differ depending on circumstances. The general how-to-take Mounjaro guide also addresses ongoing use across subsequent weeks and doses.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions